Low-dose verapamil in middle-aged and el
โ
Jawad H. Ahmed; Henry L. Elliott; Peter A. Meredith; John L. Reid
๐
Article
๐
1992
๐
Springer US
๐
English
โ 482 KB
This study investigated the cardiac responses and pharmacokinetics following the acute and chronic administration of verapamil in 14 middle-aged and elderly patients with ischemic heart disease (age range 42-76 years). There were small significant reductions in heart rate during chronic treatment, b